Human Oncology & Pathogenesis Program
The Alan Hanash Lab
Alan Hanash is an Assistant Member of Memorial Sloan Kettering and an Attending Physician on the Adult Bone Marrow Transplant Service in the Department of Medicine. Dr. Hanash’s research focuses on the immunology of hematopoietic transplantation and immune-mediated mechanisms of tissue damage and regeneration.
Lindemans CA*, Calafiore M*, Mertelsmann AM*, O’Connor MH*, Dudakov JA, Jenq RR, Velardi E, Young LF, Smith OM, Lawrence G, Ivanov JA, Fu Y, Takashima S, Hua G, Martin ML, O’Rourke KP, Lo Y, Mokry M, Romera-Hernandez M, Cupedo T, Dow L, Nieuwenhuis EE, Shroyer NF, Liu C, Kolesnick R, van den Brink MRM*, and Hanash AM*. Interleukin-22 Promotes Intestinal Stem Cell-Mediated Epithelial Regeneration. Nature. 2015 Dec 24;528(7583): 560-4.
Geiger TL, Abt MC, Gasteiger G, Firth M, O’Connor M, van den Brink MR, Pamer EG, Hanash AM*, Sun JC*. Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J Exp Med. 2014 Aug 25;211(9):1723-31.
Hanash AM, Kappel LW, Yim NL, Nejat RA, Goldberg GL, Smith OM, Rao UK, Dykstra L, Na IK, Holland AM, Liu C, Murphy GF, Leonard WJ, Heller G, van den Brink MR. Abrogation of donor T cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood. 2011 Jul 14;118(2):446-55.
Alan M. Hanash, MD, PhD
- Physician-scientist Alan Hanash studies transplant immunology and immune-mediated mechanisms of tissue damage and regeneration.
- MD, University of Miami
- ASCI Young Physician-Scientist Award (2014)
- Amy Strelzer Manasevit Research Program Scholar (2014)
- ASH Outstanding Abstract Achievement Award for Anna Mertelsmann (2013)
- ASH Scholar Award for Junior Faculty (2012)
- ASBMT New Investigator Award (2011)
Get in Touch
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Alan M. Hanash discloses the following relationships and financial interests:
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.